Comparison of Long-term Safety of the Combination Product QVA149A Against Placebo and Standard of Care Treatment in Chronic Obstructive Pulmonary Disease Patients With Moderate to Severe Airflow Limitation
Clinical trial NCT01610037 · COMPLETED
Trial details
- NCT number
- NCT01610037
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-01
- Primary completion
- 2015-02-01
- Enrollment
- 1215
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.